Related Experiment Video
Updated: Dec 25, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[AN ASSESSMENT OF REAL AND POTENTIAL LOSSES DUE TO PREMATURE DEATH FROM CEREBROVASCULAR DISEASES AS A TOOL FOR
N Rynhach1, O Kuryk2, T Cherniy3
11Ptoukha Institute for Demography and Social Studies of the National Academy of Sciences of Ukraine.
Ukraine lost over 116 million years of potential life due to cerebrovascular diseases in 2018, primarily affecting men. This highlights a significant public health burden compared to developed nations.
Area of Science:
- Public Health
- Demography
- Epidemiology
Background:
- Cerebrovascular diseases represent a significant cause of premature mortality globally.
- Understanding the burden of these diseases is crucial for public health policy and resource allocation.
Purpose of the Study:
- To calculate and estimate the years of potential life lost (YPLL) due to premature mortality from cerebrovascular diseases in Ukraine.
- To determine the proportion of YPLL from cerebrovascular diseases relative to all circulatory system diseases.
- To compare Ukraine's YPLL from cerebrovascular diseases with selected developed countries.
Main Methods:
- Utilized official data from the State Statistics Service of Ukraine for 2018 on mortality by gender, age, and cause of death.
- Employed the method of potential demography to estimate demographic losses.
- Conducted comparative analysis using the European mortality database (MDB) and Global Burden of Disease study data.
Main Results:
- In 2018, Ukraine lost 116,563 thousand man-years due to premature mortality from cerebrovascular diseases.
- This accounted for over 18% of total YPLL from all cardiovascular diseases.
- Men constituted 69.1% of the total YPLL, indicating a significant gender disparity.
Conclusions:
- Ukraine experiences substantial YPLL from cerebrovascular diseases, exceeding that of many developed nations.
- The findings underscore the need for targeted strategies and programs to combat cerebrovascular diseases.
- YPLL assessment serves as a valuable tool for decision-making and evaluating the effectiveness of interventions.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

